Lewis Bender
Director Ejecutivo en INTENSITY THERAPEUTICS, INC. .
Fortuna: 8 M $ al 30/04/2024
Cargos activos de Lewis Bender
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. | Presidente | 01/04/2012 | - |
| Director Ejecutivo | 01/04/2012 | - | |
| Fundador | 01/01/2012 | - | |
| Director/Miembro de la Junta | 01/01/2012 | - | |
| Presidente | 01/01/2012 | - |
Historial de carrera de Lewis Bender
Antiguos cargos conocidos de Lewis Bender.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| INTERLEUKIN GENETICS, INC | Director/Miembro de la Junta | 17/02/2011 | 23/08/2012 |
| Director Ejecutivo | 22/01/2008 | 23/08/2012 | |
| EMISPHERE TECHNOLOGIES, INC. | Director Ejecutivo | 01/01/1993 | 01/12/2007 |
| Director Técnico/Científico/I+D | 01/01/1993 | 01/12/2007 | |
| Presidente | 01/01/1993 | 01/12/2007 |
Formación de Lewis Bender.
| University of Pennsylvania | Graduate Degree |
| Massachusetts Institute of Technology | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Estadísticas
Internacional
| Estados Unidos | 7 |
Operativa
| Chief Executive Officer | 3 |
| Director/Board Member | 2 |
| President | 2 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| INTENSITY THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 2 |
|---|---|
Interleukin Genetics, Inc.
 Interleukin Genetics, Inc. Pharmaceuticals: MajorHealth Technology Interleukin Genetics, Inc. engages in the marketing and development of proprietary genetic tests for chronic inflammatory diseases and health-related conditions focuses on metabolism and inflammation. The company was founded in 1986 and is headquartered in Waltham, MA. | Health Technology |
Emisphere Technologies, Inc.
 Emisphere Technologies, Inc. Pharmaceuticals: MajorHealth Technology Emisphere Technologies, Inc. is a commercial stage specialty pharmaceutical company, which engages in the development of new formulations of existing products and chemical entities, using Eligen Technology. Its product pipelines include eligen B12, eligen12.com, eligen B12 information, and purchase eligen B12. The company was founded in 1986 and is headquartered in Roseland, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- Lewis Bender
- Experiencia